BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16621347)

  • 1. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Jun; 164(1):16-23. PubMed ID: 16356667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration.
    Diel P; Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Schleipen B; Thevis M; Vollmer G; Zierau O
    Toxicol Lett; 2008 Apr; 177(3):198-204. PubMed ID: 18325697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
    Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
    Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
    Parr MK; Blatt C; Zierau O; Hess C; Gütschow M; Fusshöller G; Opfermann G; Schänzer W; Diel P
    Endocrinology; 2011 Dec; 152(12):4718-28. PubMed ID: 21990312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping.
    Diel P; Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O
    Toxicol Lett; 2007 Feb; 169(1):64-71. PubMed ID: 17254722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
    Yarrow JF; McCoy SC; Borst SE
    Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin heavy chain expression pattern as a marker for anabolic potency: desoxymethyltestosterone (madol), norandrostenedione and testosterone repress MHC-IIb expression and stimulate MHC-IId/x expression in orchiectomized rat gastrocnemius muscle.
    Frese S; Velders M; Schleipen B; Schänzer W; Bloch W; Diel P
    Arch Toxicol; 2011 Jun; 85(6):635-43. PubMed ID: 20957349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
    Parr MK; Laudenbach-Leschowsky U; Höfer N; Schänzer W; Diel P
    Toxicol Lett; 2009 Jul; 188(2):137-41. PubMed ID: 19446246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid.
    Labrie F; Luu-The V; Calvo E; Martel C; Cloutier J; Gauthier S; Belleau P; Morissette J; Lévesque MH; Labrie C
    J Endocrinol; 2005 Feb; 184(2):427-33. PubMed ID: 15684350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator.
    Piu F; Gardell LR; Son T; Schlienger N; Lund BW; Schiffer HH; Vanover KE; Davis RE; Olsson R; Bradley SR
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):129-37. PubMed ID: 18164613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
    Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK
    J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic-androgenic steroid interaction with rat androgen receptor in vivo and in vitro: a comparative study.
    Feldkoren BI; Andersson S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):481-7. PubMed ID: 15876413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
    Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
    J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant.
    Wilson VS; Lambright C; Ostby J; Gray LE
    Toxicol Sci; 2002 Dec; 70(2):202-11. PubMed ID: 12441365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.